Journals / Harran Üniversitesi Veteriner Fakültesi Dergisi / 2018 / Cilt: 7 - Sayı: 2

Effects of Oleuropein on Hyperglycemia, Total Oxidant and Antioxidant Capacity in Streptozotosin-Diabetic Rats Treated with Metformin and Insulin

Streptozotosin ile Diyabet Oluşturulmuş ve Metformin-İnsülin ile Diyabet Tedavisi Gören Ratlarda, Oleuropeinin Hiperglisemi, Total Oksidan ve Total Antioksidan Düzeyleri Üzerine Etkileri

Pages
138–143
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that plasma TAC levels of G3 were statistically higher than the control (P<0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, it was aimed to investigate the effects of oleuropein on hyperglycemia and oxidant-antioxidant levels in metformin-insulin treated streptozotocin-diabetic rats.
📊
Key Findings & Data:For this purpose, 40 Sprague-Dawley rats were used.
💡
Conclusion & Impact:It was found that plasma TAC levels of G3 were statistically higher than the control (P<0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabet · İnsulin · Metformine

Abstract

In this study, it was aimed to investigate the effects of oleuropein on hyperglycemia and oxidant-antioxidant levels in metformin-insulin treated streptozotocin-diabetic rats. For this purpose, 40 Sprague-Dawley rats were used. Animals were divided into 5 groups as 4 experimental and 1 Control each containing 8 rats. 1 ml isotonic NaCl solution was injected intraperitoneally (ip) to the Control group while 50 mg/kg STZ ip was given to the G1, 50 mg/kg STZ + 100 mg/kg Metformin + 4 IU/kg insulin ip was given to the G2, 50 mg/kg STZ + 100 mg/kg Metformin + 4 IU/kg insulin ip and 30 mg/kg orally oleuropein was given to the G3 and 50 mg/kg STZ ip and 30 mg/kg oleuropein orally was given to the G4. Blood glucose values were statistically higher in the experimental groups than the control after streptozotocin administration (P<0.001, P<0.01, P<0.01 respectively). Plasma Total Antioxidant Capacity (TAC) of G2 and G3 were statistically higher than G1 (P<0.001). It was found that plasma TAC levels of G3 were statistically higher than the control (P<0.05). It was determined that the G1 (P<0.001), G2 (P<0.01) and G3 (P<0.05) group had significantly higher plasma Total Oxidant Capacity (TOC) than the control group. TAC levels in the liver of the experimental groups were determined to be statistically insignificant according to the control group. The liver TOC levels of the G2 and G4 group were significantly higher than the control group (P<0.01, P<0.001 respectively). In conclusion, the use of oleuropein alone did not affect the blood glucose level, the live weight, the plasma and the liver TAC and TOC levels, but the use of metformin and insulin with oleuropein as an antioxidant and free radical scavenger following to the rising oxidation in diabetes were supported and strengthen the system.

Özet

Bu çalışmada, streptozotosin ile diyabet oluşturulmuş ve metformin ve insülin ile diyabet tedavisi gören ratlarda, oleuropeinin hiperglisemi, oksidan-antioksidan düzeyleri üzerine etkilerinin araştırılması amaçlandı. Bu maksatla, 40 adet erkek Sprague Dawley rat kullanıldı. Ratlar her grupta 8 hayvan bulunacak şekilde 4 deney ve 1 kontrol grubu olmak üzere 5 gruba ayrıldı. Kontrol grubuna %0.09 NaCl intraperitoneal (ip) uygulandı. G1’e 50 mg/kg STZ ip, G2’ye 50 mg/kg STZ + 100 mg/kg metformin + 4 İU/kg insülin ip, G3’e 50 mg/kg STZ + 100 mg/kg metformin + 4 İU/kg insülin ip ve 30 mg/kg oleuropein oral olarak ve G4’e 50 mg/kg STZ ip olarak ve 30 mg/kg oleuropein oral olarak uygulandı. Streptozotosin uygulandıktan sonraki 3, 10 ve 21. günlerde deneme gruplarının kan glukoz değerleri kontrol grubuna göre istatistiksel olarak önemli düzeyde yüksek bulunmuştur (sırasıyla P<0.001, P<0.01, P<0.01). Plazma total antioksidan kapasiteleri gruplar arasında kıyaslandığında, G2 ve G3 grubunun Total Antioksidan Kapasite (TAC) düzeyleri, G1 grubuna göre istatistiksel olarak daha yüksek belirlenmiştir (P<0.001). Kontrol grubu ile deneme gurupları arasında kıyaslama yapıldığında G3 grubunun TAC düzeylerinin, kontrol grubuna göre istatistiksel olarak yüksek olduğu belirlenmiştir (P<0.05). G1 (P<0.001), G2 (P<0.01) ve G3 (P<0.05) grubunun plazma Total Oksidan Kapasitelerinin (TOC) kontrol grubuna göre istatistiksel olarak yüksek olduğu belirlenmiştir. Deneme gruplarının karaciğer TAC düzeylerinin kontrol grubuna göre istatistiksel olarak önemsiz olduğu tespit edildi. Karaciğer total oksidan kapasiteleri gruplar arasında kıyaslandığında G2 grubu ile G4 gurubunun TOC düzeylerinin kontrol grubuna göre istatistiksel olarak yüksek olduğu (sırasıyla P<0.01, P<0.001) belirlenmiştir. Sonuç olarak oleuropeinin tek başına kullanımının kan glukoz düzeyini, canlı ağırlığı ve plazma ile karaciğer TAC ve TOC kapasitelerini etkilemediği, ancak diyabette yükselen oksidasyona karşılık, metformin ve insülinle birlikte kullanımının antioksidan sisteme destek olduğu ve serbest radikal tutucu etkiyi kuvvetlendirdiği düşünülmektedir.

🔖

Cite This Article

KAMİLOĞLU, N. N., HASTÜRK, H. D. (2022). Effects of Oleuropein on Hyperglycemia, Total Oxidant and Antioxidant Capacity in Streptozotosin-Diabetic Rats Treated with Metformin and Insulin. Harran Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 7 - Sayı: 2, 138–143. https://ajindex.com/articles/534259

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Abou-Seif MA, Youssef AA, 2004: Evaluation of some biochemical changes in diabetic patients. Clinica Chimica Acta, 346, 161–170.
  2. Al-Azzawie HF, Alhamdani MS, 2006: Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci, 78, 1371-1377. American Diabetes Association (ADA) 2005: Standards of medical care in diabetes, Diabetes Care 28, 34-36.
  3. Asgary S, Naderi GA, Sarraf ZN, Vakili R, 2002: The inhibitory effects of pure flavonoids on in vitro protein glycosylation. J Herb Pharmacother, 2, 47–55.
  4. Aslan M, Orhan DD, Orhan N, Sezik E, Yeşilada E, 2007: In vivo antidiabetic and antioxidant potential of Helichrysum plicantaum ssp. Plicatum capitulums in streptozotocin-induced-diabetic rats. J Ethonopharmacol, 109, 54–59.
  5. Cusi K, DeFronzo RA, 1998: Metformin: a review of its metabolic effects. Diabetes Rev, 6, 89-131.
  6. Davie SJ, Gould BJ, Yudkin JS, 1992: Effect of vitamin C on glycosylation of proteins. Diabetes, 41, 167–173.
  7. Emanuelli B, Glondu M, Filloux C, Peraldi P, Obberghen EV, 2004: The potential role of SOCS-3 in the interleukin-induced desensitization of insulin signaling in pancreatic-cells. Diabetes, 53, 97-103.
  8. Farah R, Shurtz-Swirski R, Lapin O, 2008: Intensification of oxidative stress and inflammation in Type 2 diabetes despite antihyperglycemic treatment. Cardiovasc Diabetol, 7, 20. Galli C, Visioli F, 1999: Antioxidant and other activities of phenolics in olives/olive oil, typical components of the mediterranean diet. Lipids, 34, 23-26.
  9. Garrido-Fernandez A, Fernandez-Diez MJ, Adams MR, 1997: Table Olives: Production and Processing. 1st ed., 495, Chapman & Hall, London, UK. Kumar RS, Anthrayose CV, Iyer KV, Vimala B, Shashidhar S, 2001: Lipid peroxidation and diabetic retinopathy. Indian Med Sci, 55, 133-138.
  10. Lean ME, Noroozi M, Kelly I, Burns J, Talwar D, Sattar N, Crozier A, 1999: Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes, 48, 176–181.
  11. Lee MS, Hsu CC, Wahlqvist ML, Tsai HN, Chang YH, Huang YC, 2011: Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer, 11, 20. Lee SH, Kwon KI, 2004: Pharmacokinetic-pharmacodynamic modeling for the relationship between glucose-lowering effect and plasma concentration of metformin in volunteers. Arch Pharm Res, 27, 806-810.
  12. Lhommeau I, Douillard S, Bigot E, Benoit I, Krempf M, Pat